ITGAM and acute myeloid leukemia: Pharmacological inhibition of 1C metabolism resulted in increased expression of CD11b, indicating that SHIN1 treatment induces myeloid differentiation in AML cells, and, therefore, the effect is not specific to K562 and JURL-MK1 cells and erythroid differentiation (Supplementary Fig. 4g).